Rob Bresnahan purchased REGN (Regeneron Pharmaceuticals Inc) on May 15, 2025 with an estimated value between $1,000 and $15,000. This trade was filed under undisclosed. The stock is currently up 30.2% from the trade price.

Rob Bresnahan

Republican· house

Pennsylvania

REGN

Regeneron Pharmaceuticals Inc

Health Care

Trade Details

Transaction

Purchase

Trade Date

May 15, 2025(10 months ago)

Disclosed

Jun 10, 202526d gap

Owner

undisclosed

Estimated Value

$1,000 – $15,000

Trade Price

$584.99

Price Today

$761.85

Return (if held)

+30.2%

Rob Bresnahan bought $REGN at $584.99 on May 15, 2025

View all 3 trades on REGN

Price Change Since Trade

+30.2%